我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Current Challenges and Opportunities in Developing Potential Vaccine, Stem Cell and Drug Therapy Candidates: Further Inspection of Therapeutic Options for Coronavirus Disease 2019

Fatemeh Mansouri

Background: Due to the increasing occurrence of novel Coronavirus disease 2019 (COVID-19) among people of different ages around the world, there is an urgent need for an effective medical treatment. Several approaches have been used for controlling and preventing progression of infection in patients, according to their clinical symptoms and laboratory test results in different populations. Exponential growth and poor response to current treatments make it necessary to further examine the novel Coronavirus.

Main body: Here, we presented a brief introduction to the transmission, genomic structure, function, symptoms and clinical tests for COVID-19 in clinics to highlight the most relevant and recent advances in the current approaches for every stage of infection; to evaluate the challenges and opportunities in developing drugs, vaccines and stem cell therapies in clinical trials; and to focus on the role of personalized genomics and medicine in the severity of disease and response to current treatments. The proper selection of a therapeutic option is critical in every stage of infection and can directly affect immune responses to viral infections.

Conclusion: It is necessary for governments, healthcare systems and pharmaceutical companies to concentrate on the use of global communication networks based on population genomics to develop effective drugs and vaccines that can be novel tools for reducing the hospitalization rate and mortality.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。